Article

Swanton, C., Nicke, B., Schuett, M., Eklund, A. C., Ng, C., Li, Q. Y., Hardcastle, T., Lee, A., Roy, R., East, P., Kschischo, M., Endesfelder, D., Wylie, P., Kim, S. N., Chen, J. G., Howell, M., Ried, T., Habermann, J. K., Auer, G., Brenton, J. D., Szallasi, Z., Downward, J. (2009) Chromosomal instability determines taxane response. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 106 (21). pp. 8671-8676. ISSN 0027-8424

Cranshaw, I. M., Gikas, P. D., Fisher, C., Thway, K., Thomas, J. M., Hayes, A. J. (2009) Clinical outcomes of extra-thoracic solitary fibrous tumours. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 35 (9). pp. 994-998. ISSN 0748-7983

Ray-Coquard, I., Cropet, C., Van Glabbeke, M., Sebban, C., Le Cesne, A., Judson, I., Tredan, O., Verweij, J., Biron, P., Labidi, I., Guastalla, J., Bachelot, T., Perol, D., Chabaud, S., Hogendoorn, P. C. W., Cassier, P., Dufresne, A., Blays, J., European Org Res & Treatment Canc, [Group Author] (2009) Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas. CANCER RESEARCH, 69 (13). pp. 5383-5391. ISSN 0008-5472

Sleijfer, S., Ray-Coquard, I., Papai, Z., Le Cesne, A., Scurr, M., Schoeffski, P., Collin, F., Pandite, L., Marreaud, S., De Brauwer, A., Van Glabbeke, M., Verweij, J., Blay, J. (2009) Pazopanib, a Multikinase Angiogenesis Inhibitor, in Patients With Relapsed or Refractory Advanced Soft Tissue Sarcoma: A Phase II Study From the European Organisation for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC Study 62043). JOURNAL OF CLINICAL ONCOLOGY, 27 (19). pp. 3126-3132. ISSN 0732-183X

Constantinidou, A., Jones, R. L., Scurr, M., Al-Muderis, O., Judson, I. (2009) Pegylated liposomal doxorubicin, an effective, well-tolerated treatment for refractory aggressive fibromatosis. EUROPEAN JOURNAL OF CANCER, 45 (17). pp. 2930-2934. ISSN 0959-8049

Banerji, U., Affolter, A., Judson, I., Marais, R., Workman, P. (2008) BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors. MOLECULAR CANCER THERAPEUTICS, 7 (4). pp. 737-739. ISSN 1535-7163

Arkenau, H. T., Olmos, D., Ang, J. E., de Bono, J., Judson, I., Kaye, S. (2008) Clinical outcome and prognostic factors for patients treated within the context of a phase I study: the Royal Marsden Hospital experience. BRITISH JOURNAL OF CANCER, 98 (6). pp. 1029-1033. ISSN 0007-0920

Tabernero, J., Rojo, F., Calvo, E., Burris, H., Judson, I., Hazell, K., Martinelli, E., Cajal, S. R. Y., Jones, S., Vidal, L., Shand, N., Macarulla, T., Ramos, F. J., Dimitrijevic, S., Zoellner, U., Tang, P., Stumm, M., Lane, H. A., Lebwohl, D., Baselga, J. (2008) Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: A phase I tumor pharmacodynamic study in patients with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY, 26 (10). pp. 1603-1610. ISSN 0732-183X

Drilon, A. D., Popat, S., Bhuchar, G., D'Adamo, D. R., Keohan, M. L., Fisher, C., Antonescu, C. R., Singer, S., Brennan, M. F., Judson, I., Maki, R. G. (2008) Extraskeletal Myxoid Chondrosarcoma A Retrospective Review From 2 Referral Centers Emphasizing Long-term Outcomes With Surgery and Chemotherapy. CA-A CANCER JOURNAL FOR CLINICIANS, 113 (12). pp. 3364-3371. ISSN 0007-9235

Hanna, S. A., Qureshi, Y. A., Bayliss, L., David, L. A., O'Donnell, P., Judson, I. R., Briggs, T. W. R. (2008) Late widespread skeletal metastases from myxoid liposarcoma detected by MRI only. WORLD JOURNAL OF SURGICAL ONCOLOGY, 6 . ISSN 1477-7819

Chung, Y. L., Troy, H., Kristeleit, R., Aherne, W., Jackson, E., Atadja, P., Griffiths, J. R., Judson, I. R., Workman, P., Leach, M. O., Beloueche-Babari, M. (2008) Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts. NEOPLASIA, 10 (4). pp. 303-313. ISSN 1522-8002

Schlemmer, M., Reichardt, P., Verweij, J., Hartmann, J. T., Judson, I., Thyss, A., Hogendoorn, P. C. W., Marreaud, S., Van Glabbeke, M., Blay, J. Y. (2008) Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group. EUROPEAN JOURNAL OF CANCER, 44 (16). pp. 2433-2436. ISSN 0959-8049

O'Donnell, A., Faivre, S., Burris, H. A., Rea, D., Papadimitrakopoulou, V., Shand, N., Lane, H. A., Hazell, K., Zoellner, U., Kovarik, J. M., Brock, C., Jones, S., Raymond, E., Judson, I. (2008) Phase I pharmacokinetic and pharmacodynamic study of the oral mammalian target of rapamycin inhibitor everolimus in patients with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY, 26 (10). pp. 1588-1595. ISSN 0732-183X

Sarker, D., Molife, R., Evans, T. R. J., Hardie, M., Marriott, C., Butzberger-Zimmerli, P., Morrison, R., Fox, J. A., Heise, C., Louie, S., Aziz, N., Garzon, F., Michelson, G., Judson, I. R., Jadayel, D., Braendle, E., de Bono, J. S. (2008) A phase I pharmacokinetic and pharmacodynamic study of TKI258, an oral, multitargeted receptor tyrosine kinase inhibitor in patients with advanced solid tumors. CLINICAL CANCER RESEARCH, 14 (7). pp. 2075-2081. ISSN 1078-0432

Judson, I. (2008) State-of-the-art approach in selective curable tumours: soft tissue sarcoma. ANNALS OF ONCOLOGY, 19 (Supplement 7). pp. 166-169. ISSN 0923-7534

Murray, M., Hatcher, H., Jessop, F., Williams, D., Carroll, N., Bulusu, R., Judson, I. (2008) Treatment of wild-type gastrointestinal stromal tumor (WT-GIST) with imatinib and sunitinib. PEDIATRIC BLOOD & CANCER, 50 (2). pp. 386-388. ISSN 1545-5009

Judson, I., Demetri, G. (2007) Advances in the treatment of gastrointestinal stromal tumours. ANNALS OF ONCOLOGY, 18 (Supplement 10). pp. 20-24. ISSN 0923-7534

Leahy, M., Ray-Coquard, I., Verweij, J., Le Cesne, A., Duffaud, F., Hogendoorn, P. C. W., Fowst, C., de Balincourt, C., di Paola, E. D., van Glabbeke, M., Judson, I., Blay, J. Y. (2007) Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. EUROPEAN JOURNAL OF CANCER, 43 (2). pp. 308-315. ISSN 0959-8049

Maloney, A., Clarke, P. A., Naaby-Hansen, S., Stein, R., Koopman, J. O., Akpan, A., Yang, A., Zvelebil, M., Cramer, R., Stimson, L., Aherne, W., Banerji, U., Judson, I., Sharp, S., Powers, M., deBilly, E., Salmons, J., Walton, M., Burlingame, A., Waterfield, M., Workman, P. (2007) Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin. CANCER RESEARCH, 67 (7). pp. 3239-3253. ISSN 0008-5472

Scurr, M. (2007) How much molecular pathology is required to treat GI stromal tumours? EJC SUPPLEMENTS, 5 (5). pp. 440-441. ISSN 1359-6349

Verweij, J., Casali, P. G., Kotasek, D., Le Cesne, A., Reichard, P., Judson, I. R., Issels, R., Oosterom, A. T., Glabbeke, M., Blay, J. Y. (2007) Imatinib does not induce cardiac left ventricular failure in gastrointestinal stromal tumours patients: Analyis of EORTC-ISG-AGITG study 62005. EUROPEAN JOURNAL OF CANCER, 43 (6). pp. 974-978. ISSN 0959-8049

Hayes, A. J., Neuhaus, S. J., Clark, M. A., Thomas, J. M. (2007) Isolated limb perfusion with melphalan and tumor necrosis factor alpha for advanced melanoma and soft-tissue sarcoma. ANNALS OF SURGICAL ONCOLOGY, 14 (1). pp. 230-238. ISSN 1068-9265

Legge, F., Eaton, D., Molife, R., Ferrandina, G., Judson, I., de Bono, J., Kaye, S. (2007) Participation of patients with gynecological cancer in phase I clinical trials: Two years experience in a major cancer center. GYNECOLOGIC ONCOLOGY, 104 (3). pp. 551-556. ISSN 0090-8258

Benson, C., White, J., De Bono, J., O'Donnell, A., Raynaud, F., Cruickshank, C., McGrath, H., Walton, M., Workman, P., Kaye, S., Cassidy, J., Gianella-Borradori, A., Judson, I., Twelves, C. (2007) A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days. BRITISH JOURNAL OF CANCER, 96 (1). pp. 29-37. ISSN 0007-0920

Karavasilis, V., Seddon, B. M., Ashley, S., Al-Muderis, O., Fisher, C., Judson, I. (2007) Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma - Retrospective analysis and identification of prognostic factors in 488 patients. CANCER, 112 (7). pp. 1585-1591. ISSN 0008-543X

Pitsinis, V., Khan, A. Z., Cranshaw, I., Allum, W. H. (2007) Single center experience of laparoscopic vs. open resection for gastrointestinal stromal tumors of the stomach. HEPATO-GASTROENTEROLOGY, 54 (74). pp. 606-608. ISSN 0172-6390

Lee, J. C., Thomas, J. M., Phillips, S., Fisher, C., Moskovic, E. (2006) Aggressive fibromatosis: MRI features with pathologic correlation. AMERICAN JOURNAL OF ROENTGENOLOGY, 186 (1). pp. 247-254. ISSN 0361-803X

Demetri, G. D., van Oosterom, A. T., Garrett, C. R., Blackstein, M. E., Shah, M. H., Verweij, J., McArthur, G., Judson, I. R., Heinrich, M. C., Morgan, J A., Desai, J.D Fletcher, C., George, S., Bello, C. L., Huang, X., Baum, C. M., Casali, P. G. (2006) Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. LANCET, 368 (9544). pp. 1329-1338. ISSN 0140-6736

Scurr, M., Judson, I. (2006) How to treat the Ewing's family of sarcomas in adult patients. ONCOLOGIST, 11 (1). pp. 65-72. ISSN 1083-7159

Debiec-Rychter, M., Sciot, R., Le Cesne, A., Schlemmer, M., Hohenberger, P., van Oosterom, A. T., Blay, J. Y., Leyvraz, S., Stul, M., Casali, P. G., Zalcberg, J., Verweij, J., Van Glabbeke, M., Hagemeijer, A., Judson, I., EORTC Soft Tissue Bone Sarcoma Grp, [Group Author], Italian Sarcoma Grp, [Group Author], Australasian GastroIntestinal, [Group Author] (2006) KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. EUROPEAN JOURNAL OF CANCER, 42 (8). pp. 1093-1103. ISSN 0959-8049

Al-Saffar, N. M. S., Troy, H., de Molina, A. R., Jackson, L. E., Madhu, B., Griffiths, J. R., Leach, M. O., Workman, P., Lacal, J. C., Judson, I. R., Chung, Y. L. (2006) Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. CANCER RESEARCH, 66 (1). pp. 427-434. ISSN 0008-5472

Nielsen, O. S., Reichardt, P., Christensen, T. B., Pink, D., Daugaard, S., Hermans, C., Marreaud, S., van Glabbeke, M., Blay, J., Judson, I. (2006) Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx (R)) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas. EUROPEAN JOURNAL OF CANCER, 42 (14). pp. 2303-2309. ISSN 0959-8049

Lee, C. P., de Jonge, M. J. A., O'Donnell, A. E., Schothorst, K. L., Hanwell, J., Chick, J. B., Brooimans, R. A., Adams, L. M., Drolet, D. W., de Bono, J. S., Kaye, S. B., Judson, I. R., Verweij, J. (2006) A phase I study of a new nucleoside analogue, OSI-7836, using two administration schedules in patients with advanced solid malignancies. CLINICAL CANCER RESEARCH, 12 (9). pp. 2841-2848. ISSN 1078-0432

Johnson, P., Geldart, T., Fumoleau, P., Pinel, M. C., Nguyen, L., Judson, I. (2006) Phase I study of vinflunine administered as a 10-minute infusion on days 1 and 8 every 3 weeks. INVESTIGATIONAL NEW DRUGS, 24 (3). pp. 223-231. ISSN 0167-6997

Van Glabbeke, M., Verweij, J., Casali, P. G., Simes, J., Le Cesne, A., Reichardt, P., Issels, R., Judson, I. R., van Oosterom, A. T., Blay, J. Y. (2006) Predicting toxicities for patients with advanced gastrointestinal stromal tumours treated with imatinib: A study of the European Organisation for Research and Treatment of Cancer, the Italian Sarcoma Group, and the Australasian Gastro-Intestinal Trials Group (EORTC-ISG-AGITG). EUROPEAN JOURNAL OF CANCER, 42 (14). pp. 2277-2285. ISSN 0959-8049

Boden, R. A., Clark, M. A., Neuhaus, S. J., A'Hern, J. R., Thomas, J. M., Hayes, A. J. (2006) Surgical management of soft tissue sarcoma in patients over 80 years. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 32 (10). pp. 1154-1158. ISSN 0748-7983

Karavasilis, V., Malamou-Mitsi, V., Briasoulis, E., Tsanou, E., Kitsou, E., Kalofonos, H., Fountzilas, G., Fotsis, T., Pavlidis, N. (2005) Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC CANCER, 5 . ISSN 1471-2407

Leach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths, J. R., Horsman, M. R., Jackson, A., Jayson, G. C., Judson, I. R., Knopp, M. V., Maxwell, R. J., McIntyre, D., Padhani, A. R., Price, P., Rathbone, R., Rustin, G. J., Tofts, P. S., Tozer, G. M., Vennart, W., Waterton, J. C., Williams, S. R., Workman, P. (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. BRITISH JOURNAL OF CANCER, 92 (9). pp. 1599-1610. ISSN 0007-0920

Clark MA, Thomas JM (2005) Delay in referral to a specialist soft-tissue sarcoma unit. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 31 (4). pp. 443-448. ISSN 0748-7983

Jones, R. L., Fisher, C., Al-Muderis, O., Judson, I. R. (2005) Differential sensitivity of liposarcoma subtypes to chemotherapy. EUROPEAN JOURNAL OF CANCER, 41 (18). pp. 2853-2860. ISSN 0959-8049

Hughes MJ, Thomas JM, Fisher C, Moskovic EC (2005) Imaging features of retroperitoneal and pelvic schwannomas. CLINICAL RADIOLOGY, 60 (8). pp. 886-893. ISSN 0009-9260

Judson I, Ma PM, Peng B, Verweij J, Racine A, di Paola FD, van Glabbeke M, Dimitrijevic S, Scurr M, Dumez H, van Oosterom A (2005) Imatinib pharmacokinetics in patients with gastrointestinal stromal tumour: a retrospective population pharmacokinetic study over time. EORTC Soft Tissue and Bone Sarcoma Group. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 55 (4). pp. 379-386. ISSN 0344-5704

Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PCW, Brown M, Bertulli R, Judson IR (2005) Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study. JOURNAL OF CLINICAL ONCOLOGY, 23 (24). pp. 5795-5804. ISSN 0732-183X

Scurr M, Judson I (2005) Neoadjuvant and adjuvant therapy for extremity soft tissue sarcomas. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 19 (3). p. 489. ISSN 0889-8588

Zalcberg JR, Verweij J, Casali PG, Le Cesne A, Reichardt P, Blay JY, Schlemmer M, Van Glabbeke M, Brown M, Judson IR (2005) Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800 mg after progression on 400 mg. EUROPEAN JOURNAL OF CANCER, 41 (12). pp. 1751-1757. ISSN 0959-8049

Banerji, U., Walton, M., Raynaud, F., Grimshaw, R., Kelland, L., Valenti, M., Judson, I., Workman, P. (2005) Pharmacokinetic-pharmacodynamic relationships for the heat shock protein 90 molecular chaperone inhibitor 17-allylamino, 17-demethoxygeldanamycin in human ovarian cancer xenograft models. CLINICAL CANCER RESEARCH, 11 (19). pp. 7023-7032. ISSN 1078-0432

O'Donnell, A., Padhani, A., Hayes, C., Kakkar, A. J., Leach, M., Trigo, J. M., Scurr, M., Raynaud, F., Phillips, S., Aherne, W., Hardcastle, A., Workman, P., Hannah, A., Judson, I. (2005) A phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end points. BRITISH JOURNAL OF CANCER, 93 (8). pp. 876-883. ISSN 0007-0920

Le Cesne A, Blay JY, Judson I, Van Oosterom A, Verweij J, Radford J, Lorigan P, Rodenhuis S, Ray-Coquard I, Bonvalot S, Collin F, Jimeno J, Di Paola E, Van Glabbeke M, Nielsen OS (2005) Phase II study of ET-743 in advanced soft tissue sarcomas: A European Organisation for the Research and Treatment of Cancer (EORTC) soft tissue and bone sarcoma group trial. JOURNAL OF CLINICAL ONCOLOGY, 23 (3). pp. 576-584. ISSN 0732-183X

Spurrell, E. L., Fisher, C., Thomas, J. M., Judson, I. R. (2005) Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital. ANNALS OF ONCOLOGY, 16 (3). pp. 437-444. ISSN 0923-7534

Therasse, P., Le Cesne, A., Van Glabbeke, M., Verweij, J., Judson, I. (2005) RECIST vs. WHO: Prospective comparison of response criteria in an EORTC phase II clinical trial investigating ET-743 in advanced soft tissue sarcoma. EUROPEAN JOURNAL OF CANCER, 41 (10). pp. 1426-1430. ISSN 0959-8049

Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM (2005) Surgical management of primary and recurrent retroperitoneal liposarcoma. BRITISH JOURNAL OF SURGERY, 92 (2). pp. 246-252. ISSN 0007-1323

Phillips SR, A'Hern R, Thomas JM (2004) Aggressive fibromatosis of the abdominal wall, limbs and limb girdles. BRITISH JOURNAL OF SURGERY, 91 (12). pp. 1624-1629. ISSN 0007-1323

Spurrell, E. L., Yeo, Y. C., Rollason, T. P., Judson, I. R. (2004) A Case of Ovarian Fibromatosis and Massive Ovarian Oedema Associated With Intra-Abdominal Fibromatosis, Sclerosing Peritonitis and Meig's Syndrome. SARCOMA, 8 (4). pp. 113-121. ISSN 1357-714X

Hayes AJ, Alexander N, Clark MA, Thomas JM (2004) Elastofibroma: a rare soft tissue tumour with a pathognomonic anatomical location and clinical symptom. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 30 (4). pp. 450-453. ISSN 0748-7983

Lee, Y. F., John, M., Falconer, A., Edwards, S., Clark, J., Flohr, P., Roe, T., Wang, R. B., Shipley, J., Grimer, R. J., Mangham, D. C., Thomas, J. M., Fisher, C., Judson, I., Cooper, C. S. (2004) A gene expression signature associated with metastatic outcome in human leiomyosarcomas. CANCER RESEARCH, 64 (20). pp. 7201-7204. ISSN 0008-5472

Behranwala KA, Roy P, Giblin V, A'Hern R, Fisher C, Thomas JM (2004) Intra-abdominal metastases from soft tissue sarcoma. JOURNAL OF SURGICAL ONCOLOGY, 87 (3). pp. 116-120. ISSN 0022-4790

Harries, M., O'Donnell, A., Scurr, M., Reade, S., Cole, C., Judson, I., Greystoke, A., Twelves, C., Kaye, S. (2004) Phase I/II study of DHA-paclitaxel in combination with carboplatin in patients with advanced malignant solid tumours. BRITISH JOURNAL OF CANCER, 91 (9). pp. 1651-1655. ISSN 0007-0920

Blay JY, Le Cesne A, Verweij J, Scurr M, Seynaeve C, Bonvalot S, Hogendoorn P, Jimeno J, Evrard V, van Glabbeke M, Judson I (2004) A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours. EUROPEAN JOURNAL OF CANCER, 40 (9). pp. 1327-1331. ISSN 0959-8049

Behranwala KA, A'Hern R, Thomas JM (2004) Primary malignant tumors of the iliopsoas compartment. JOURNAL OF SURGICAL ONCOLOGY, 86 (2). pp. 78-83. ISSN 0022-4790

Behranwala, K. A., A'Hern, R., Omar, A. M., Thomas, J. M. (2004) Prognosis of lymph node metastasis in soft tissue sarcoma. ANNALS OF SURGICAL ONCOLOGY, 11 (7). pp. 714-719. ISSN 1068-9265

Popat, S., Nicholson, A. G., Fisher, C., Harmer, C., Moskovic, E., Murday, V. A., Houlston, R. S. (2004) Pulmonary masses presenting 11 years after abdominal surgery - Diagnosis: Pulmonary hyalinizing granuloma. RESPIRATION, 71 (3). pp. 295-297. ISSN 0025-7931

Thomas JM, Clark MA (2004) Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 30 (6). pp. 686-691. ISSN 0748-7983

Hayes AJ, Mostyn-Jones A, Koban MU, A'Hern R, Burton P, Thomas JM (2004) Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. BRITISH JOURNAL OF SURGERY, 91 (2). pp. 242-247. ISSN 0007-1323

Judson, I. (2004) Systemic therapy of soft tissue sarcoma: an improvement in outcome. ANNALS OF ONCOLOGY, 15 (Supplement 4). iv193-iv196. ISSN 0923-7534

Livi L, Andreopoulou E, Shah N, Paiar F, Blake P, Judson I, Harmer C (2004) Treatment of uterine sarcoma at the Royal Marsden Hospital from 1974 to 1998. CLINICAL ONCOLOGY, 16 (4). pp. 261-268. ISSN 0936-6555

Debiec-Rychter M, Dumez H, Judson I, Wasag B, Verweij J, Brown M, Dimitrijevic S, Sciot R, Stul M, Vranck H, Scurr M, Hagemeijer A, Van Glabbeke M, van Oosterom AT (2004) Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group. EUROPEAN JOURNAL OF CANCER, 40 (5). pp. 689-695. ISSN 0959-8049

Behranwala KA, Latifaj B, Blake P, Barton DPJ, Shepherd JH, Thomas JM (2004) Vulvar soft tissue tumors. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 14 (1). pp. 94-99. ISSN 1048-891X

Blay JY, van Glabbeke M, Verweij J, van Oosterom AT, Le Cesne A, Oosterhuis JW, Judson I, Nielsen OS (2003) Advanced soft-tissue sarcoma: a disease that is potentially curable for a subset of patients treated with chemotherapy. EUROPEAN JOURNAL OF CANCER, 39 (1). pp. 64-69. ISSN 0959-8049

Behranwala, K. A., Thomas, J. M. (2003) 'Aggressive' angiomyxoma: a distinct clinical entity. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 29 (7). pp. 559-563. ISSN 0748-7983

Leach, M. O., Brindle, K. M., Evelhoch, J. L., Griffiths, J. R., Horsman, M. R., Jackson, A., Jayson, G., Judson, I. R., Knopp, M. V., Maxwell, R. J., McIntyre, D., Padhani, A. R., Price, P., Rathbone, R., Rustin, G., Tofts, P. S., Tozer, G. M., Vennart, W., Waterton, J. C., Williams, S. R., Workman, P. (2003) Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. BRITISH JOURNAL OF RADIOLOGY, 76 (Special Issue 1). S87-S91. ISSN 0007-1285

Behranwala, K. A,. Barry, P., A'Hern, R., Thomas, J. A. (2003) Buttock soft tissue sarcoma: Clinical features, treatment, and prognosis. ANNALS OF SURGICAL ONCOLOGY, 10 (8). pp. 961-971. ISSN 1068-9265

Jeyaderan N, Sohaib SA, Thomas JM, Jeyarajah A, Shepherd JH, Fisher C (2003) Imaging features of aggressive angiomyxoma. CLINICAL RADIOLOGY, 58 (2). pp. 157-162. ISSN 0009-9260

Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PCW, di Paola ED, Brown M, Nielsen OS (2003) Imatinib mesylate (STI-571 Glivec (R), Gleevec (TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study. EUROPEAN JOURNAL OF CANCER, 39 (14). pp. 2006-2011. ISSN 0959-8049

Clark MA, Thomas JM (2003) Major amputation for soft-tissue sarcoma. BRITISH JOURNAL OF SURGERY, 90 (1). pp. 102-107. ISSN 0007-1323

Burkill, G. J. C., Badran, M., Al-Muderis, O., Thomas, J. M., Judson, I. R., Fisher, C., Moskovic, E. C. (2003) Malignant gastrointestinal stromal tumor: distribution, imaging features, and pattern of metastatic spread. RADIOLOGY, 226 (2). pp. 527-532. ISSN 0033-8419

Lee, Y. F., John, M., Edwards, S., Clark, J., Flohr, P., Maillard, K., Edema, M., Baker, L., Mangham, D. C., Grimer, R., Wooster, R., Thomas, J. M., Fisher, C., Judson, I., Cooper, C. S. (2003) Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling. BRITISH JOURNAL OF CANCER, 88 (4). pp. 510-515. ISSN 0007-0920

Clark MA, Thomas JM (2003) Portsite recurrence after laparoscopy for staging of retroperitoneal sarcoma. SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES, 13 (4). pp. 290-291. ISSN 1530-4515

Livi, L., Shah, N., Paiar, F., Fisher, C., Judson, I., Moskovic, E., Thomas, M., Harmer, C. (2003) Treatment of epithelioid sarcoma at the Royal Marsden Hospital. SARCOMA, 7 (3—4). pp. 149-152. ISSN 1357-714X

Livi L, Paiar F, Shah N, Blake P, Villanucci A, Amunni G, Barca R, Judson I, Lodge N, Meldolesi E, Simontacchi G, Piperno G, Galardi A, Scoccianti S, Biti GP, Harmer C (2003) Uterine sarcoma: Twenty-seven years of experience. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 57 (5). pp. 1366-1373. ISSN 0360-3016

Patocskai, E. J., Tabatabaian, M., Thomas, M. J. (2002) Cellular schwannoma: a rare presacral tumour. CANADIAN JOURNAL OF SURGERY, 45 (2). pp. 141-144. ISSN 0008-428X

Judson, I., Leahy, M., Whelan, J., Lorigan, P., Verrill, M., Grimer, R., Robinson, M. (2002) A guideline for the management of gastrointestinal stromal tumour (GIST). SARCOMA, 6 (3). pp. 83-87. ISSN 1357-714X

Behranwala KA, Thomas JM (2002) How I do it - Division of the psoas tendon in the management of benign psoas tumors. JOURNAL OF SURGICAL ONCOLOGY, 81 (2). pp. 105-107. ISSN 0022-4790

Kumar P, Judson I, Nicholson AG, Ladas G (2002) Mediastinal hemangioma: successful treatment by alpha-2a interferon and postchemotherapy resection. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 124 (2). pp. 404-406. ISSN 0022-5223

Van Glabbeke M, Verweij J, Judson I, Nielsen OS (2002) Progression-free rate as the principal end-point for phase II trials in soft-tissue sarcomas. EUROPEAN JOURNAL OF CANCER, 38 (4). pp. 543-549. ISSN 0959-8049

van Oosterom AT, Mouridsen HT, Nielsen OS, Dombernowsky P, Krzemieniecki K, Judson I, Svancarova L, Spooner D, Hermans C, Van Glabbeke M, Verweij J (2002) Results of randomised studies of the EORTC Soft Tissue and Bone Sarcoma Group (STBSG) with two different ifosfamide regimens in first- and second-line chemotherapy in advanced soft tissue sarcoma patients. EUROPEAN JOURNAL OF CANCER, 38 (18). pp. 2397-2406. ISSN 0959-8049

Behranwala KA, Clark MA, Thomas JM (2002) Soft-tissue tumours of the perineum. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 28 (4). pp. 437-442. ISSN 0748-7983

Hoeber, I., Spillane, A. J., Fisher, C., Thomas, J. M. (2001) Accuracy of biopsy techniques for limb and limb girdle soft tissue tumors. ANNALS OF SURGICAL ONCOLOGY, 8 (1). pp. 80-87. ISSN 1068-9265

Ng C, Stebbing J, Judson I (2001) Cardiac metastasis from a myxoid liposarcoma. CLINICAL ONCOLOGY, 13 (5). pp. 384-385. ISSN 0936-6555

Cleator, S., Cottrill, C., Harmer, C. (2001) Pattern of local recurrence after conservative surgery and radiotherapy for soft tissue sarcoma. SARCOMA, 5 (2). pp. 83-88. ISSN 1357-714X

Judson I, Radford JA, Harris M, Blay J, Van Hoesel Q, Le Cesne A, Van Oosterom AT, Clemons MJ, Kamby C, Hermans C, Whittaker J, Donato di Paola E, Verweij J, Nielsen S (2001) Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL(R)/ CAELYX(R)) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group. EUROPEAN JOURNAL OF CANCER, 37 (7). pp. 870-877. ISSN 0959-8049

van Oosterom AT, Judson I, Verweij J, Stroobants S, di Paola ED, Dimitrijevic S, Martens M, Webb A, Sciot R, Van Glabbeke M, Silberman S, Nielsen OS (2001) Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study. LANCET, 358 (9291). pp. 1421-1423. ISSN 0140-6736

Verweij J, Judson I, van Oosterom A (2001) STI571: a magic bullet? EUROPEAN JOURNAL OF CANCER, 37 (15). pp. 1816-1819. ISSN 0959-8049

Book Section

Judson I, Harmer C. (2003) Sarcomas. In: Cancer in Primary Care. Martin Dunitz, London, UK, pp. 231-238. ISBN 978-190186526-4

Editorial

Gronchi, A., Judso, I., Nishida, T., Poveda, A., Martin, J., Reichardt, P., Casali, P. G., Le Cesne, A., Hohenberger, P., Blay, J. Y. (2009) Adjuvant treatment of GIST with imatinib: Solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST, the French Sarcoma Group and the Spanish Sarcoma Group (GEIS). [Editorial]

Judson, I. R. (2008) Imatinib for patients with liver or kidney dysfunction: No need to modify the dose. [Editorial]

Thomas, J. M. (2008) Sentinel lymph node biopsy in malignant melanoma. [Editorial]

Thomas, J. M. (2007) Retroperitoneal sarcoma. [Editorial]

Giblin, A. N., Hayes, A. J., Thomas, J. M. (2005) The significance of melanoma micrometastases in the sentinel lymph node. [Editorial]

Judson I (2003) Imatinib mesylate - a viewpoint by Ian Judson. [Editorial]

Patocskai, E. J., Thomas, J. M. (2002) Gastric necrosis in a patient with bulimia. [Editorial]

Letter

Thomas, J. M. (2009) Freedom of expression or protectionism in the debate on sentinel node biopsy in melanoma. [Letter]

Strauss, D. C., Thomas, J. M. (2009) What Does the Medical Profession Mean By "Standard of Care?". [Letter]

Banerji, U., de Bono, J., Judson, I., Kaye, S., Workman, P. (2008) Biomarkers in early clinical trials: The committed and the skeptics. [Letter]

Carden, C. P., Judson, I. R. (2008) Humors of tumors: Potential for interaction between cancer type and treating oncologist's personality? [Letter]

Thomas, J. M., Hayes, A. (2008) Multivariable analysis comparing outcome after sentinel node biopsy or therapeutic lymph node dissection in patients with melanoma (Br J Surg 2007; 94 : 1293-1299). [Letter]

Thomas, J. M. (2007) Authors' reply: Retroperitoneal sarcoma (Br J Surg 2007; 94: 1057-1058). [Letter]

Molife, R., Fong, P., Scurr, M., Judson, I., Kaye, S., de Bono, J. (2007) HDAC inhibitors and cardiac safety. [Letter]

Hayes, A. J., Thomas, J. M. (2006) Recurrence-free survival after sentinel node biopsy in melanoma? [Letter]

Giblin, A. V., Thomas, J. M. (2006) Sentinel lymph node biopsies for cutaneous melanoma. [Letter]

Thomas JM, Giblin AV (2005) Dermatologists should exert a greater influence over sentinel lymph node biopsy for melanoma in the UK. [Letter]

Clark, M. A., Fisher, C., Thomas, J. M. (2005) Soft-tissue sarcoma - Reply. [Letter]

Thomas, J. M. (2005) Time to re-evaluate sentinel node biopsy in melanoma post-multicenter selective lymphadenectomy trial. [Letter]

Thomas JM, Clark MA (2004) Are there guidance issues relating to sentinel node biopsy for melanoma in the UK? [Letter]

Clark MA, Hayes AJ, Thomas JM (2004) Expectoration of endobronchial sarcoma metastasis. [Letter]

Neuhaus SJ, Clark MA, Thomas JM, Judson I (2004) Gastrointestinal stromal tumours (Br J Surg 2003; 90 : 1178-1186). [Letter]

Judson I (2004) In relation to Anninga et al Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas. [Letter]

Qazi NA, Morlese JF, King DM, Ahmad RS, Gazzard BG, Nelson MR (2002) Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis. [Letter]

Review Article

Krikelis, D., Judson, I. (2010) Role of chemotherapy in the management of soft tissue sarcomas. EXPERT REVIEW OF ANTICANCER THERAPY, 10 (2). pp. 249-260. ISSN 1473-7140

Stummann, T. C., Beilmann, M., Duker, G., Dumotier, B., Fredriksson, J. M., Jones, R. L., Hasiwa, M., Kang, Y. J., Mandenius, C., Meyer, T., Minotti, G., Valentin, Y. J., Zuenkler, B. J., Bremer, S. (2009) Report and Recommendations of the Workshop of the European Centre for the Validation of Alternative Methods for Drug-Induced Cardiotoxicity. CARDIOVASCULAR TOXICOLOGY, 9 (3). pp. 107-125. ISSN 1530-7905

Judson, I. (2008) Imatinib in advanced gastrointestinal stromal tumour: when is 800 mg the correct dose? CURRENT OPINION IN ONCOLOGY, 20 (4). pp. 433-437. ISSN 1040-8746

Thomas, J. M. (2008) Prognostic false-positivity of the sentinel node in melanoma. NATURE CLINICAL PRACTICE ONCOLOGY, 5 (1). pp. 18-23. ISSN 1743-4254

Seddon BM, Cassoni AM, Galloway MJ, Rees JH, Whelan JS (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLINICAL ONCOLOGY, 17 (5). pp. 385-390. ISSN 0936-6555

Clark, M. A., Fisher, C., Judson, I., Thomas, J. M. (2005) Soft-tissue sarcomas in adults. NEW ENGLAND JOURNAL OF MEDICINE, 353 (7). pp. 701-711. ISSN 0028-4793

Neuhaus SJ, Clark MA, Hayes AJ, Thomas JM, Judson I (2005) Surgery for gastrointestinal stromal tumour in the post-imatinib era. ANZ JOURNAL OF SURGERY, 75 (3). pp. 165-172. ISSN 1445-1433

Neuhaus, S. J., Clark, M. A., Thomas, J. M. (2004) Dr. Herbert Lumley Snow, MD, MRCS (1847-1930): The original champion of elective lymph node dissection in melanoma. ANNALS OF SURGICAL ONCOLOGY, 11 (9). pp. 875-878. ISSN 1068-9265

Eisenberg, B. L., Judson, I. (2004) Surgery and imatinib in the management of GIST: Emerging approaches to adjuvant and neoadjuvant therapy. ANNALS OF SURGICAL ONCOLOGY, 11 (5). pp. 465-475. ISSN 1068-9265

Clark MA, Thomas JM (2003) Amputation for soft-tissue sarcoma. LANCET ONCOLOGY, 4 (6). pp. 335-342. ISSN 1470-2045

Saran F (2002) Recent advances in paediatric neuro-oncology. CURRENT OPINION IN NEUROLOGY, 15 (6). pp. 671-677. ISSN 1350-7540